Oocyte/embryo cryopreservation before chemotherapy for breast cancer;Congélation d'embryons ou d'ovocytes avant chimiothérapie pour cancer du sein

Gynecologie Obstetrique et Fertilite

Volumn 39, Issue 9, 2011, Pages 501-503

  Decanter, C ^a   Gligorov, J ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL TENON   (France)

Author keywords

Breast cancer; Chemotherapy; Embryo; Fertility preservation; IVF

Indexed keywords

BREAST CANCER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CRYOPRESERVATION; FEMALE; FEMALE FERTILITY; FRANCE; HUMAN; PREGNANCY;

EID: 80052263186     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2011.07.011     Document Type: Conference Paper

References (24)

1. A. Mailliez, C. Decanter, and Bonneterre J Chimiothérapie adjuvante de cancer du sein et fertilité : estimation de l'impact, options de préservation et place de l'oncologue Bull Cancer 98 7 2011 741 751
2. M. Sonmezer, and K. Oktay Fertility preservation in young women undergoing breast cancer therapy Oncologist 11 5 2006 422 434 (Pubitemid 43788268)
3. M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander Breast cancer in young women and its impact on reproductive function Hum Reprod Update 15 3 2009 323 339
4. S.S. Kim, J. Klemp, and C. Fabian Breast cancer and fertility preservation Fertil Steril 95 5 2011 1535 1543
5. N. Chabbert-Buffet, C. Uzan, J. Gligorov, S. Delaloge, R. Rouzier, and S. Uzan Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy Surg Oncol 19 1 2010 47 55
6. A.H. Partridge, and E.P. Winer Long-term complications of adjuvant chemotherapy for early stage breast cancer Breast Dis 21 2004 55 64
7. A. Reh, O. Oktem, and K. Oktay Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Fertil Steril 90 5 2008 1635 1639
8. W.J. Kil, S.D. Ahn, S.S. Shin, S.W. Lee, E.K. Choi, and J.H. Kim Treatment-induced menstrual changes in very young (< 35 years old) breast cancer patients Breast Cancer Res Treat 96 3 2006 245 250
9. C. Poirot, M.C. Vacher-Lavenu, P. Helardot, J. Guibert, L. Brugires, and P. Jouannet Human ovarian tissue cryopreservation: indications and feasibility Hum Reprod 17 6 2002 1447 1452 (Pubitemid 34661789)
10. I. Demeestere, P. Simon, S. Emiliani, A. Delbaere, and Y. Englert Orthotopic and heterotopic ovarian tissue transplantation Hum Reprod Update 15 6 2009 649 665
11. M. Sánchez-Serrano, J. Crespo, V. Mirabet, A.C. Cobo, M.J. Escribá, and C. Simón Twins born after transplantation of ovarian cortical tissue and oocyte vitrification Fertil Steril 93 1 2010 268 e11-3
12. D. de Ziegler, I. Streuli, I. Vasilopoulos, C. Decanter, P. This, and C. Chapron Cancer and fecundity issues mandate a multidisciplinary approach Fertil Steril 93 3 2010 691 696
13. B. Lawrenz, E. Neunhoeffer, M. Henes, S. Lessmann-Bechle, B. Krämer, and T. Fehm Management of fertility preservation in young breast cancer patients in a large breast cancer centre Arch Gynecol Obstet 282 5 2010 547 551
14. A. Badawy, A. Elnashar, M. El-Ashry, and M. Shahat Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertil Steril 91 3 2009 694 697
15. K. Oktay, M. Sönmezer, O. Oktem, K. Fox, G. Emons, and H. Bang Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury Oncologist 12 9 2007 1055 1056
16. K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen Hum Reprod 18 1 2003 90 95 (Pubitemid 36138857)
17. K. Oktay Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation J Clin Oncol 23 16 2005 3858 3859
18. K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation J Clin Oncol 23 19 2005 4347 4353 (Pubitemid 46207008)
19. K. Oktay, I. Türküolu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod Biomed Online 20 6 2010 783 788
20. K. Oktay, A. Hourvitz, G. Sahin, O. Oktem, B. Safro, and A. Cil Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy J Clin Endocrinol Metab 91 10 2006 3885 3890 (Pubitemid 44536859)
21. A.A. Azim, M. Costantini-Ferrando, and K. Oktay Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study J Clin Oncol 26 16 2008 2630 2635
22. N. Noyes, E. Porcu, and A. Borini Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies Reprod Biomed Online 18 6 2009 769 776
23. K. Oktay, A.P. Cil, and H. Bang Efficiency of oocyte cryopreservation: a meta-analysis Fertil Steril 86 1 2006 70 80 (Pubitemid 43962981)
24. E. Shalom-Paz, B. Almog, F. Shehata, J. Huang, H. Holzer, and R.C. Chian Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification Reprod Biomed Online 21 4 2010 566 571